Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James N Cooper

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Blood|October 20, 2017
Clonality in context: hematopoietic clones in their marrow environmentJames N Cooper, Neal S Young
Journal of the American College of Nutrition|May 31, 2007
Pistachio nut consumption and serum lipid levelsMichael J Sheridan, James N Cooper, Madeline Erario, et al.
Personalized Medicine|May 24, 2018
Role of proteomics in personalized medicineDavid H Geho, James N Cooper, Virginia Espina, et al.
JAMA|September 23, 2010
Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemiaPhillip Scheinberg, James N Cooper, Elaine M Sloand, et al.
Digestive Diseases and Sciences|July 21, 2004
Risk factors for hepatocellular carcinoma in patients with cirrhosisSteedman A Sarbah, Terry Gramlich, Abraham Younoszai, et al.
Gastroenterology|August 29, 2002
The utility of radiological imaging in nonalcoholic fatty liver diseaseSherif Saadeh, Zobair M Younossi, Erick M Remer, et al.
Cell|September 9, 2008
HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cellsAlyson Yoder, Dongyang Yu, Li Dong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III studyDavid R Nelson, James N Cooper, Jacob P Lalezari, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood|October 20, 2017
Clonality in context: hematopoietic clones in their marrow environmentJames N Cooper, Neal S Young
Journal of the American College of Nutrition|May 31, 2007
Pistachio nut consumption and serum lipid levelsMichael J Sheridan, James N Cooper, Madeline Erario, et al.
Personalized Medicine|May 24, 2018
Role of proteomics in personalized medicineDavid H Geho, James N Cooper, Virginia Espina, et al.
JAMA|September 23, 2010
Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemiaPhillip Scheinberg, James N Cooper, Elaine M Sloand, et al.
Digestive Diseases and Sciences|July 21, 2004
Risk factors for hepatocellular carcinoma in patients with cirrhosisSteedman A Sarbah, Terry Gramlich, Abraham Younoszai, et al.
Gastroenterology|August 29, 2002
The utility of radiological imaging in nonalcoholic fatty liver diseaseSherif Saadeh, Zobair M Younossi, Erick M Remer, et al.
Cell|September 9, 2008
HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cellsAlyson Yoder, Dongyang Yu, Li Dong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III studyDavid R Nelson, James N Cooper, Jacob P Lalezari, et al.
Pageof 1